HI SCR150

Requests the Governor to pursue a federal controlled substance exemption from the Drug Enforcement Administration (DEA) for Hawaii's registered medical cannabis patients to protect them from federal prosecution or discrimination.

Requests DEA registration waivers under 21 U.S.C. section 822(d) for state-licensed dispensaries to legally produce and distribute medical cannabis intrastate.

Follows up on House Concurrent Resolution 132 from the 2021 legislative session, which the Department of Health, Governor, and Attorney General have not yet acted upon.

Addresses the conflict between Hawaii's medical cannabis program (established in 2000 under Act 228) and federal Schedule I classification, which affects patients' employment, housing, firearms registration, banking access, and healthcare.

Directs the Department of Health to provide updates to the Legislature and requires certified copies be sent to Hawaii's Congressional delegation, Governor, Attorney General, and Health Director.